Alan Garber
#46,503
Most Influential Person Now
American Health Care Policy researcher; academic administrator
Alan Garber's AcademicInfluence.com Rankings
Download Badge
Economics
Alan Garber's Degrees
- Doctorate Medicine Stanford University
- PhD Economics Stanford University
Why Is Alan Garber Influential?
(Suggest an Edit or Addition)According to Wikipedia, Alan Michael Garber is an American physician, health economist, and academic administrator. He is the Provost of Harvard University. Early life and education Garber was born in 1955. He graduated from Harvard College in 1976 with an AB in economics and stayed at Harvard to earn an AM and a PhD in economics. While pursuing his PhD, he enrolled simultaneously at Stanford University, where he received an MD degree in 1983.
Alan Garber's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Economic foundations of cost-effectiveness analysis. (1997) (728)
- Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis (1999) (523)
- Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation (2011) (459)
- Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors. (2002) (338)
- Systematic Review: The Safety and Efficacy of Growth Hormone in the Healthy Elderly (2007) (331)
- Cost-Effectiveness of Alternative Test Strategies for the Diagnosis of Coronary Artery Disease (1999) (274)
- Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. (2006) (272)
- American Association of Clinical Endocrinologists’ Comprehensive Diabetes Management Algorithm 2013 Consensus Statement (2013) (271)
- Variation in Health Care Spending: Target Decision Making, Not Geography (2013) (254)
- Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis: A Cost-Effectiveness Analysis (1999) (247)
- Is American Health Care Uniquely Inefficient? (2008) (233)
- Does comparative-effectiveness research threaten personalized medicine? (2009) (220)
- Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. (1999) (215)
- Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life. (2004) (213)
- Screening for hypertension. (1990) (189)
- Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes (2011) (188)
- Consequences of health trends and medical innovation for the future elderly. (2005) (182)
- Systematic Review: The Effects of Growth Hormone on Athletic Performance (2008) (168)
- Cost-effectiveness of androgen suppression therapies in advanced prostate cancer. (2000) (161)
- Geographic variation in Medicare services. (2013) (150)
- Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. American College of Physicians. Part 1. (1996) (147)
- Technology Diffusion, Hospital Variation, and Racial Disparities Among Elderly Medicare Beneficiaries: 1989–2000 (2005) (147)
- Cost-Effectiveness of Screening for Carotid Stenosis in Asymptomatic Persons (1997) (145)
- Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group. (1997) (144)
- Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing. (1999) (143)
- A multivariate analysis of mortality and hospital admissions with high-flux dialysis. (1992) (142)
- The new technology assessment. (1990) (142)
- Case Mix, Costs, and Outcomes: Differences between Faculty and Community Services in a University Hospital (1983) (132)
- Geographic variation in health care spending in the United States: insights from an Institute of Medicine report. (2013) (132)
- Incretin-Based Therapies (2009) (127)
- A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease (2000) (125)
- 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 6. Cost effectiveness of assessment and management of risk factors. (1996) (125)
- Population Strategies to Decrease Sodium Intake and the Burden of Cardiovascular Disease (2010) (124)
- Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer. (1999) (121)
- Evidence-based coverage policy. (2001) (120)
- Theoretical Foundations of Cost-Effectiveness Analysis (1996) (117)
- Following your heart or your head: focusing on emotions versus information differentially influences the decisions of younger and older adults. (2010) (111)
- A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer. (2007) (110)
- CLINICAL GUIDELINE, PART 2: Cholesterol Screening in Asymptomatic Adults, Revisited (1996) (108)
- Gaucher disease. Current issues in diagnosis and treatment. NIH Technology Assessment Panel on Gaucher Disease. (1996) (107)
- Racial Disparity in Cardiac Procedures and Mortality Among Long‐Term Survivors of Cardiac Arrest (2003) (106)
- The role of costs in comparative effectiveness research. (2010) (105)
- Effectiveness and Cost-Effectiveness of Vaccination Against Pandemic Influenza (H1N1) 2009 (2009) (105)
- Current Approaches to Cervical-Cancer Screening (2001) (102)
- Cost-effectiveness and evidence evaluation as criteria for coverage policy. (2004) (100)
- The resting electrocardiogram as a screening test. A clinical analysis. (1989) (99)
- Cost-effectiveness of automated external defibrillators on airlines. (2001) (94)
- Cost-Effectiveness of Defending against Bioterrorism: A Comparison of Vaccination and Antibiotic Prophylaxis against Anthrax (2005) (88)
- Cost-Effectiveness of Genotype-Guided and Dual Antiplatelet Therapies in Acute Coronary Syndrome (2014) (88)
- The role of exercise testing in screening for coronary artery disease. (1989) (88)
- Evidence-based guidelines as a foundation for performance incentives. (2005) (85)
- Influence of Race on Inpatient Treatment Intensity at the End of Life (2007) (85)
- Predicting Nursing Home Utilization Among the High-Risk Elderly (1989) (84)
- Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States. (2010) (83)
- Incidental extracardiac findings at coronary CT: clinical and economic impact. (2010) (81)
- The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis. (2006) (80)
- Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography. (2005) (80)
- Essential elements of a technology and outcomes assessment initiative. (2007) (79)
- Economic Foundations of Cost Effective Analysis (1992) (77)
- Toward a 21st-Century Health Care System: Recommendations for Health Care Reform (2009) (76)
- Should we be measuring blood cholesterol levels in young adults? (1993) (75)
- Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease. (2003) (70)
- Satisfaction guaranteed--"payment by results" for biologic agents. (2007) (69)
- Research on the Comparative Effectiveness of Medical Treatments: Isues and Options for an Expanded Federal Role (2007) (69)
- Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction. (2002) (68)
- Measurement of the validity of utility elicitations performed by computerized interview. (1997) (68)
- Screening asymptomatic adults for cardiac risk factors: the serum cholesterol level. (1989) (67)
- Rosiglitazone and Outcomes for Patients With Diabetes Mellitus and Coronary Artery Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial (2013) (67)
- Insurance and Incentives for Medical Innovation (2006) (64)
- Frontiers in health policy research (1998) (61)
- Cost-effectiveness analysis of nephron sparing options for the management of small renal masses. (2010) (56)
- Developing and Testing a Multimedia Presentation of a Health-state Description (1994) (54)
- Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel Crohn's disease. (2010) (54)
- Health Care Productivity (1997) (54)
- Frontiers in Health Policy Research, Volume 1 (2002) (52)
- Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. (2013) (52)
- Impacts of informal caregiver availability on long-term care expenditures in OECD countries. (2004) (51)
- Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis. (2003) (51)
- Forecasting Nursing Home Utilization of Elderly Americans (1992) (51)
- Transcatheter Aortic Valve Replacement in Nonsurgical Candidates With Severe, Symptomatic Aortic Stenosis: A Cost-Effectiveness Analysis (2013) (49)
- Cholesterol screening in asymptomatic adults, revisited. Part 2. (1996) (48)
- Individualized Cost-Effectiveness Analysis (2011) (48)
- Costs and health consequences of cholesterol screening for asymptomatic older Americans. (1991) (46)
- Problems with the report of the Expert Panel on blood cholesterol levels in children and adolescents. (1995) (45)
- The Effect of Geriatrics Evaluation and Management on Nursing Home Use and Health Care Costs: Results From a Randomized Trial (2006) (43)
- Medical Care at the End of Life: Diseases, Treatment Patterns, and Costs (1998) (41)
- Laparoscopy in women with unexplained infertility: a cost-effectiveness analysis. (2009) (41)
- Clinical practice. Current approaches to cervical-cancer screening. (2001) (41)
- COMMITTEE ON GEOGRAPHIC VARIATION IN HEALTH CARE SPENDING AND PROMOTION OF HIGH-VALUE CARE (2013) (40)
- The effect of assessment method and respondent population on utilities elicited for Gaucher Disease (1997) (39)
- Persistence of Medicare Expenditures among Elderly Beneficiaries (1997) (39)
- Effectiveness and Cost-Effectiveness of Expanded Antiviral Prophylaxis and Adjuvanted Vaccination Strategies for an Influenza A (H5N1) Pandemic (2009) (39)
- Cost-Effectiveness of Early Colectomy With Ileal Pouch-Anal Anastamosis Versus Standard Medical Therapy in Severe Ulcerative Colitis (2012) (37)
- Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable. (2018) (37)
- Unsupervised Method for Automatic Construction of a Disease Dictionary from a Large Free Text Collection (2008) (36)
- Can technology assessment control health spending? (1994) (36)
- Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995. (2002) (35)
- Future costs and the future of cost-effectiveness analysis. (2008) (34)
- A cost-benefit analysis of preimplantation genetic diagnosis for carrier couples of cystic fibrosis. (2007) (33)
- Investigation of Unsupervised Pattern Learning Techniques for Bootstrap Construction of a Medical Treatment Lexicon (2009) (33)
- Insulin therapy in type 2 diabetes patients failing oral agents: cost‐effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US * (2007) (33)
- Nursing Home Discharges and Exhaustion of Medicare Benefits (1991) (32)
- Combining Text Classification and Hidden Markov Modeling Techniques for Structuring Randomized Clinical Trial Abstracts (2006) (32)
- Extracting Subject Demographic Information From Abstracts of Randomized Clinical Trial Reports (2007) (31)
- Knowing loved ones' end-of-life health care wishes: attachment security predicts caregivers' accuracy. (2011) (30)
- Cholesterol screening guidelines. Consensus, evidence, and common sense. (1997) (30)
- Modernizing device regulation. (2010) (30)
- The potential impact of comparative effectiveness research on U.S. Health Care expenditures (2010) (30)
- Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995. (2002) (28)
- Interim Report of the Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Health Care (2013) (28)
- Committing to Exercise: Contract Design for Virtuous Habit Formation (2010) (28)
- Costs and benefits of prenatal screening for cystic fibrosis. (1991) (28)
- A concise review of the cost-effectiveness of coronary heart disease prevention. (2000) (28)
- Triglyceride concentration and coronary heart disease (1994) (28)
- Cost-effectiveness of Screening BRCA 1 / 2 Mutation Carriers With Breast Magnetic Resonance Imaging (2006) (27)
- A Menu without Prices (2008) (26)
- An uncertain future for cardiovascular drug development? (2009) (26)
- Management of acute kidney injury in the intensive care unit: a cost-effectiveness analysis of daily vs alternate-day hemodialysis. (2008) (26)
- Long-Term Care, Wealth, and Health of the Disabled Elderly Living in the Community (1987) (25)
- Type 2 diabetes and cardiovascular risk factors (2011) (25)
- Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis. (2009) (25)
- The promise of health care cost containment. (2007) (25)
- Cost-effectiveness and cost-benefit analysis of using methotrexate vs Goeckerman therapy for psoriasis. A pilot study. (1998) (25)
- How CER could pay for itself--insights from vertebral fracture treatments. (2011) (25)
- Nudges in Exercise Commitment Contracts: A Randomized Trial (2015) (24)
- How the Patient-Centered Outcomes Research Institute can best influence real-world health care decision making. (2011) (23)
- The costs of decedents in the Medicare program: implications for payments to Medicare + Choice plans. (2004) (22)
- Willingness-to-pay utility assessment: feasibility of use in normative patient decision support systems (1997) (22)
- Using Cost-Effectiveness Analysis To Target Cholesterol Reduction (2000) (21)
- Predicting high-risk cholesterol levels (1994) (20)
- No price too high? (1992) (20)
- Evaluating the federal role in financing health-related research. (1996) (20)
- Invariance and Inconsistency in Utility Ratings (2005) (20)
- To Comfort Always: The Prospects of Expanded Social Responsibility for Long-Term Care (1995) (20)
- Where to draw the line against cholesterol. (1989) (19)
- An economic analysis of conservative management versus active treatment for men with localized prostate cancer. (2012) (18)
- Does Cost-Effectiveness Analysis Make a Difference? (2001) (18)
- The U.S. Physician Workforce: Serious Questions Raised, Answers Needed (2004) (17)
- Uber's Message for Health Care. (2016) (17)
- Combining text classification and Hidden Markov Modeling techniques for categorizing sentences in randomized clinical trial abstracts. (2006) (17)
- Effectiveness and Cost-Effectiveness of Vaccination against Pandemic (H1N1) 2009 (2009) (17)
- Financing Health Care for Elderly Americans in the 1990s (1994) (17)
- Cost-effectiveness Analysis of Adjunct VSL#3 Therapy Versus Standard Medical Therapy in Pediatric Ulcerative Colitis (2011) (16)
- Health plans' coverage determinations for technology-based interventions: the case of electrical bone growth stimulation. (2004) (16)
- Triglyceride concentration and coronary heart disease (1994) (16)
- Autologous chondrocyte transplantation of the knee. (2003) (15)
- Simple counts of ADL dependencies do not adequately reflect older adults' preferences toward states of functional impairment. (2008) (15)
- Multimedia Quality of Life Assessment: Advances with FLAIR (2005) (15)
- Practice guidelines and cholesterol policy. (1991) (15)
- Rise of pay for performance: implications for care of people with chronic kidney disease. (2007) (15)
- Creating the Costliest Orphan: The Orphan Drug Act in the Development of Ceredase™ (1992) (15)
- Quality of life assessment software for computer-inexperienced older adults: multimedia utility elicitation for activities of daily living (2002) (14)
- Cholesterol screening should be targeted. (1997) (14)
- Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL (2016) (13)
- The price of growth in the medical-device industry. (2006) (13)
- Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease (1992) (13)
- Significantly Better Glycemic Control and Weight Reduction with Liraglutide, a Once-Daily Human GLP- 1 Analog, Compared With Glimepiride: All as Monotherapy In Type 2 Diabetes. (2008) (13)
- Mortality, hospital admissions, and medical costs of end-stage renal disease in the United States and Manitoba, Canada. (1997) (13)
- Cost Effectiveness of Coronary Heart Disease Prevention Strategies in Adults (1998) (12)
- Making the most of Pap testing. (1998) (12)
- Variation in Health Care Spending (2013) (12)
- Cost Effectiveness and Payment Policy (2011) (12)
- Health and Economic Benefits of Early Vaccination and Nonpharmaceutical Interventions for a Human Influenza A (H7N9) Pandemic (2014) (11)
- Costs and Benefits of Prenatal Screening for Cystic Fibrosis (1987) (11)
- Unsupervised Method for Extracting Machine Understandable Medical Knowledge from a Large Free Text Collection (2009) (11)
- Learning From Excess Pandemic Deaths. (2021) (10)
- Analysis of a Case: Training Synergies Between Medical Informatics and Health Services Research: Successes and Challenges (2002) (10)
- To use technology better. (2006) (10)
- Differences between faculty and community services in a university hospital. (1984) (9)
- Diagnosis and Medicare Expenditures at the End of Life (1998) (9)
- Alglucerase for Gaucher's disease: dose, costs and benefits. (1994) (9)
- Future Health and Medical Care Spending of the Elderly (2005) (9)
- Cost‐containment and Financing the Long‐term Care of the Elderly (1988) (9)
- Is High-Flux Dialysis Cost-Effective? (1993) (8)
- Three large-scale changes to the Medicare program could curb its costs but also reduce enrollment. (2013) (8)
- Performance of the RAND Appropriateness Criteria (2003) (8)
- • Realistic Rigor in Cost-Effectiveness Methods (1999) (8)
- Corporate treatment for the ills of academic medicine. (2004) (8)
- The cost of VA‐sponsored research (1996) (7)
- The who, what, when, where, whom, and how of hospitalist care (2002) (7)
- Data Science: What the Educated Citizen Needs to Know (2019) (6)
- Annals of Internal Medicine Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis A Cost-Effectiveness Analysis (1999) (6)
- Information on Cost-Effectiveness : An Essential Product of a National Comparative Effectiveness Program (2008) (6)
- Trends in the Use of Intensive Procedures at the End of Life (2001) (6)
- Is Something Better than Nothing? Health Insurance Expansions and the Content of Coverage. (2003) (5)
- The confirmatory trial in comparative-effectiveness research. (2009) (5)
- Modeling the Health and Medical Care Spending of the Future Elderly (2008) (5)
- Exciting times for pharmacological research in diabetes, obesity and metabolism (1999) (5)
- Competition, integration and incentives: the quest for efficiency in the English NHS (2011) (5)
- Cause-Specific Mortality Among Medicare Enrollees (1996) (4)
- Medical Innovation: Promise and Pitfalls (2003) (4)
- Health Care and Information Technology: Growing Up Together (2001) (4)
- Payment Source and Episodes of Institutionalization (1992) (4)
- Benefits versus profits: has the orphan drug act gone too far? (1994) (3)
- Disease Prevention Research at NIH: An Agenda for All. Workshop J: Prevention strategies, economic realities, and identification of prevention research needs. (1994) (3)
- Cost-effectiveness analysis as a measure of value. (1996) (3)
- Coping with Chronic Disease? Chronic Disease and Disability in Elderly American Population 1982-1999 (2009) (3)
- Articles on Diagnostic Tests: A New Series and an Invitation to Authors (2002) (2)
- Insurers can borrow from research into medical effectiveness to help them allocate medical resources wisely. (2001) (2)
- The Narrowing Dispersion of Medicare Expenditures 1997 to 2005 (2010) (2)
- Effects of Competition Under Prospective Payment (2002) (2)
- From Misfortune to Mortality: Sudden Loss of Wealth and Increased Risk of Death. (2018) (2)
- Benefits Versus Profits (1994) (2)
- Triglyceride concentration and coronary heart disease (1994) (2)
- Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial". (2014) (2)
- Systematic Review: The Effects of Growth Hormone on Athletic (2008) (2)
- A computer program for statistically-based decision analysis (1990) (2)
- Two years of treatment with liraglutide, a human GLP-1 analogue, offers sustained and greater reduction with HbA1c, FPG, PPG and weight compared with glimepiride, with lower glycaemic risk, in patients with type 2 diabetes: LEAD-3 extension study (2009) (2)
- Medical innovation: promise & pitfalls (2003) (1)
- 653 Cost-Effectiveness of Alternative Diagnostic Strategies for Patients with Suspected Small-Bowel Crohn's Disease (2009) (1)
- US Healthcare Reform: Monumental Health System Transformation or Fatally Flawed Compromise? (2010) (1)
- Costs and Control of Antibiotic Resistance (1982) (1)
- Is having more preapproval data the best way to assure drug safety? (2008) (1)
- Health Care Financing and Information Technology: A Historical Perspective (2006) (1)
- Alglucerase for Gaucher’s Disease (1994) (1)
- Population Strategies to Decrease Sodium Intake (2010) (1)
- Expanding Role of Technology Assessment in Health Policy (1991) (1)
- Cost-Effectiveness of Diagnosis and Screening for Coronary Artery Disease with Electron Beam Computed Tomography (2000) (1)
- Program report: Health care (2001) (1)
- Geographic differences in US health care spending--reply. (2014) (1)
- Introduction to Frontiers in Health Policy Research, Volume 6 (2003) (1)
- PANACEA OR PERSONALIZED MEDICINE? OPTIMIZING ANTIPLATELET THERAPY IN ACUTE CORONARY SYNDROME – A COST-EFFECTIVENESS ANALYSIS (2012) (1)
- Cognitive rehabilitation for traumatic brain injury in adults. (2008) (1)
- The effect of intensive treatment of diabetes mellitus. (1994) (1)
- Medicare savings from conservative management of low back pain. (2018) (1)
- Empirical Analysis of Geographic Variation (2013) (1)
- Does the United States Spend Too Much on Medical Care (2001) (1)
- O-236: Cost effectiveness of laparoscopy and empiric infertility treatment in unexplained infertility (2006) (1)
- Cost-Effectiveness of 3 Methods to Enhance the Sensitivity of Papanicolaou Testing (1999) (1)
- Commentary: the impact of Medicare coverage policies on health care utilization. (2008) (1)
- Trends in Prescription Drug Use by the Disabled Elderly (2009) (1)
- "Following your heart or your head: Focusing on emotions versus information differentially influences the decisions of younger and older adults": Correction to Mikels et al. (2010). (2010) (1)
- Costs and benefits of prenatal genetic screening for cystic fibrosis (1988) (1)
- CONTRIBUTORS TO GEOGRAPHIC VARIATION IN MEDICARE SPENDING (2013) (1)
- Effectiveness and Cost-Effectiveness of Surgical Masks and N-95 Respirators for the Next Influenza Pandemic. (2009) (1)
- Poster presentationsPreimplantation genetic diagnosisA cost-benefit analysis of preimplantation genetic diagnosis for carrier couples of cystic fibrosis (2007) (1)
- Polymerase Chain Reaction for Diagnosis of HIV Infection (1997) (0)
- Coverage of New Health Care Technologies in the US: An Investigation of Principles, Processes and the Use of Cost-Effectiveness Information (2007) (0)
- Regression Model Specifications with “Clusters” of Predictors (2013) (0)
- Analysis of Ritonavir for the Treatment of HIV Disease in Children (1998) (0)
- In comparison to the money spent to develop new technologies, Americans spend a paltry sum on finding ways to improve the use of technologies we already have. (2006) (0)
- Tests for Coronary Artery Disease (1999) (0)
- Contributors (2009) (0)
- Testing Strategies in the Initial Management of Patients with Community-Acquired Pneumonia (2015) (0)
- The Cost-Effectiveness of Automated External Defibrillators on U.S. Airlines (2010) (0)
- Harvard University Price Adjustment Memorandums (2013) (0)
- Editorial Type 2 diabetes and cardiovascular risk factors (2011) (0)
- Cost-Effectiveness of Low-Molecular-Weight Heparins for Deep Venous Thrombosis (2000) (0)
- Abstract 16076: Cost-effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF vs. PREVAIL (2015) (0)
- Major Changes to Medicare Would Cut Costs but Also Squeeze Enrollment and Raise Spending for Seniors (2013) (0)
- PO414 LIRAGLUTIDE IN COMBINATION WITH METFORMIN PROVIDES GREATER PPG CONTROL VS METFORMIN MONOTHERAPY ACROSS ALL 3 MAIN MEALS (2014) (0)
- P Cardiac Rhythm Disorders rends in Implantable ardioverter-Defibrillator Racial Disparity (2016) (0)
- Low plasma cholesterol level increased the risk for death in men (1992) (0)
- Footsteps on a rocky path. (2000) (0)
- Statement of Task (2013) (0)
- Accuracy of on-the-spot analysis for vholesterol (1991) (0)
- Lipid-lowering diet for regression of atherosclerosis (1992) (0)
- Introduction to Frontiers in Health Policy Research, Volume 7 (2004) (0)
- Abstract 18327: Angiographic Criteria Determine Effectiveness of CABG among Patients with Diabetes and Stable Ischemic Heart Disease: Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial (2010) (0)
- Societal Perspective: Comment (2006) (0)
- Front matter, acknowledgments (2004) (0)
- Perspectiv e Cost-Effectiveness: Will The Public Buy It Or Balk? The time has come for an open public debate on how to incorporate cost to achieve an optimal allocation of resources. (2004) (0)
- Teaching Learners How to Approach Family Decisions as a Process (2020) (0)
- Front matter, acknowledgment, table of contents (2003) (0)
- K/doqi Tm Disclaimer K/doqi Advisory Board Members K/doqi Tm Nutrition Work Group Membership Adult Work Group Members Pediatric Work Group Members Nkf-doqi Advisory Council* Nkf-doqi Steering Committee* Acronyms and Abbreviations List Abbreviation Term A1-ag A1-acid Glycoprotein Abw Ef Adjusted Edem (0)
- Harvard Market Variables Memorandum (2013) (0)
- Health Affairs spending ? Can technology assessment control health (2001) (0)
- Laparoscopy in Women With Unexplained Infertility: ACost-Effectiveness Analysis (2009) (0)
- 31st Annual Meeting of the Society of Medical Decision Making Abstracts. (2010) (0)
- A team augmented with a medical team coordinator led to fewer days in hospital and greater satisfaction with care among patients admitted to a general medical clinical teaching unit (1993) (0)
- Indexing Value in Medicare: The Role of Geographic Area Performance (2013) (0)
- Kudos For Clinton Plan Issue (1994) (0)
- ARTICLES Cost-Effectiveness of Androgen Suppression Therapies in Advanced Prostate Cancer (2000) (0)
- Exercise and behavioral rehabilitation soon after myocardial infarction was cost-effective (1994) (0)
- Introduction to Frontiers in Health Policy Research, Volume 1 (1998) (0)
- Striving to be the Best (2010) (0)
- NBER WORKING PAPER SERIES THE PRAGMATIST’S GUIDE TO COMPARATIVE EFFECTIVENESS RESEARCH (2011) (0)
- COMPARATIVE EFFECTIVENESS ANALYSIS OF BARIATRIC SURGERY VERSUS MEDICAL TREATMENT ALONE FOR PATIENTS WITH BMIS BETWEEN 30 AND 35 (2012) (0)
- Introduction to Frontiers in Health Policy Research, Volume 8 (2005) (0)
- Population Strategies to Decrease Sodium Intake. Authors' reply (2010) (0)
- Summary of Empirical Modeling Methodology (2013) (0)
- Expanded Social Responsibility for Long-Term Care (1996) (0)
- NBER BUREAU OF ECONOMIC RESEARCH (2001) (0)
- GEOGRAPHY AND INDEXING VALUE (2013) (0)
- Degludec insulin compared to glargin insulin diminishes the number of nocturnal hypoglycemic episodes: results after 1 year in randomized basal-bolus trials in type 1 (DT1) and type 2 (DT2) diabetics (2012) (0)
- EVALUATION OF A GEOGRAPHIC VALUE INDEX (2013) (0)
- Response to Pokharna and Kanna: Initial treatment with rosiglitazone/metformin fixed‐dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes (2008) (0)
- Utilization of Elderly Americans (1994) (0)
- Theoretical review of modern concepts of stress tolerance in Germany (2017) (0)
- Introduction to Frontiers in Health Policy Research, Volume 5 (2002) (0)
- In the face of rising health care spending, we must redouble our efforts to establish value for that spending. (2007) (0)
- RESEARCH FRAMEWORK AND STATISTICAL MODELING APPROACH (2013) (0)
- Published in cooperation with Kaiser Foundation Health Plan and Southern California Permanente Medical Group. (2006) (0)
- Introduction to Frontiers in Health Policy Research, Volume 4 (2001) (0)
- Cost-effectiveness of Breast Magnetic Resonance Imaging to Screen (2006) (0)
- Payment and Organizational Reforms to Improve Value (2013) (0)
- Selected Results of the Committee's Commissioned Empirical Analyses (2013) (0)
- Note from the Editor (2010) (0)
- Introduction to Frontiers in Health Policy Research, Volume 3 (1999) (0)
- PDB26 COMPARATIVE EVALUATION OF THE LONG-TERM COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 AND INSULIN GLARGINE IN A SUB-POPULATION OF POORLY CONTROLLED PATIENTS WITH TYPE-2 DIABETES RECEIVING ORAL ANTIDIABETIC AGENTS (2005) (0)
- impact on the development of insurance law , among other ways through the prolific insurance law opinions of Judge (2014) (0)
- Impact Of Dependency In Activities Of Daily Living (adl) On Mood In Older Adults. (2004) (0)
- Investigations in the Economics of Aging: The Value of Progress Against Cancer in the Elderly (2011) (0)
- B type natriuretic peptide testing was more cost effective than conventional diagnosis in patients with acute dyspnoea (2007) (0)
- The Resting Electrocardiogram as a Screening Test (2020) (0)
- Alglucerase: The Debate Continues (1995) (0)
- Does NCEP screening detect abnormal lipoprotein levels? (1991) (0)
- PO416 LIRAGLUTIDE MONOTHERAPY PROVIDES SUPERIOR PPG CONTROL AFTER ALL THREE DAILY MEALS VS. SULPHONYLUREA MONOTHERAPY (2014) (0)
- A CONCISE REVIEW OF THE CORONARY HEART DISEASE PREVENTION COST-EFFECTIVENESS OF (2000) (0)
- This paper was presented at a colloquium entitled ‘ ‘ Science , Technology , and the Economy , ’ ’ organized by Ariel Pakes (1996) (0)
- Rate of Recurrent-Confirmed Hypoglycemia with Insulin Degludec vs. Insulin Glargine in Patients with Type 2 Diabetes (2013) (0)
This paper list is powered by the following services:
Other Resources About Alan Garber
What Schools Are Affiliated With Alan Garber?
Alan Garber is affiliated with the following schools:
